Refine
Year of publication
Document Type
- Article (8)
- Doctoral Thesis (1)
Has Fulltext
- yes (9)
Is part of the Bibliography
- no (9)
Keywords
Institute
- Medizin (5)
- Biochemie und Chemie (2)
- Biowissenschaften (1)
- Pharmazie (1)
- Physik (1)
The enzyme quinol:fumarate reductase (QFR) from the anaerobic e-proteobacterium Wolinella succinogenes is part of the anaerobic respiratory system of this organism. It couples the reduction of fumarate to succinate to the oxidation of menaquinol to menaquinone. W. succinogenes uses fumarate as terminal electron acceptor and can use various substrates (e.g., formate or molecular hydrogen) as electron donors. The concerted catalytic substrate turnover of either a hydrogenase or a formate dehydrogenase in conjunction with QFR contributes to the generation of an electrochemical potential gradient across the bacterial plasma membrane, which is used for the phosphorylation of ADP with inorganic phosphate, Pi, to ATP. In addition to an FAD (in subunit A) and three iron-sulfur clusters (in subunit B), QFR binds a low- and a high-potential heme b group in its transmembrane subunit C, as was ultimately shown in the crystal structure at 2.2 Å resolution (Lancaster et al., 1999, Nature 402, 377– 385). Both hemes are part of the electron transport chain between the two catalytic sites of this redox enzyme. The midpoint potentials of the hemes are well established but their assignment to the distal and proximal positions in the structure had not yet been determined. Furthermore, QFR from W. succinogenes has been proposed to exhibit a novel coupling mechanism of transmembrane electron and proton transfer, which has been described in the so-called “E-pathway” hypothesis (Lancaster, 2002, Biochim. Biophys. Acta 1565, 215–231). The aim of this project was to characterize the relationship between structure and function of QFR and to investigate the details of the proposed coupling mechanism (“Epathway”) with the help of computer-based electrostatic calculations on the QFR wild-type (WT) coordinates, and electrochemically induced FTIR and VIS difference spectroscopy on the QFR WT and available variant enzymes (in particular enzyme variant E180Q, in which the glutamic acid at position C180 has been replaced by a glutamine). 1.) It was demonstrated in this study that the diheme-containing QFR exhibits stable and reproducible electrochemically induced FTIR difference bands in the midinfrared range from 1800 cm-1 to 1000 cm-1 that reflect transitions from the reduced to the oxidized state of the enzyme. The spectral features that were observed in the FTIR difference spectra are fully reversible when changing from a reductive to an oxidative reference potential at the working electrode and vice versa. This indicates that the underlying redox reactions of the enzyme at the gold grid working electrode are also fully reversible under the applied experimental conditions. The same reversible spectral redox behavior in the visible range could also be ascertained for the Soret- and a-band of the two heme b groups of QFR. This behavior allowed to reliably determine the heme b midpoint potentials of QFR at various pH values. Analysis of the FTIR difference spectra in the amide I range yields evidence for structural reorganizations of the polypeptide backbone upon the electrochemically induced redox reaction. 2.) The redox titrations of the high- and low-potential heme b of QFR as simulated by multiconformation continuum electrostatics (MCCE) calculations showed a very high level of agreement with respect to the experimentally observed midpoint potentials of the heme b groups at pH 7. As determined with the help of the theoretical calculations, prominent features governing the differences in redox potential between the two hemes are the higher loss of reaction field energy for the proximal heme and the stronger destabilization of the oxidized form of the proximal heme due to several buried and ionized Arg and Lys residues. The explicit incorporation of crystallographically identified water molecules in the calculations had a noticeable effect on the absolute values of the determined midpoint potentials, although the relative difference of the two obtained midpoints did not change significantly. The results of the electrostatic calculations clearly showed that the lowpotential heme corresponds to the distal position bD in the structure, and that the high-potential heme is identical to the proximal heme bP. This assignment could previously not be achieved unequivocally with experimental methods. 3.) In addition, the currently discussed mechanism of coupled electron and proton transfer in the QFR of W. succinogenes (i.e., the “E-pathway” hypothesis) is further supported by the results of this study. The simulations of intermediate states of electron transfer via the heme b groups show that the protonation state of the key amino acid residue Glu C180 depends on the redox states of the heme groups as suggested in the “E-pathway” hypothesis. This result yields a possible mechanism for the coupling of transient transmembrane proton transfer via Glu C180 to the electron transfer via the heme b groups, since Glu C180 could be part of a “proton wire” and its redox-dependent protonation state could serve as the regulatory element of the “E-pathway”. Furthermore, the results of simulated heme reduction indicate that the side chain of Glu C180 also changes its conformation with respect to the redox state of the hemes. Both major results concerning the role of Glu C180, the change of protonation as well as the reorientation of the side chain upon reduction of the heme groups, are consistent with the results from electrochemically induced FTIR difference spectroscopy: Of particular interest was the spectral range above 1710 cm-1, where C=O stretching vibrations of protonated COOH carboxyl groups absorb, because those groups can act as proton donors, respectively acceptors, and can be involved in intra-protein proton transfer reactions. It was possible to observe signals of such protonated carboxyl groups originating from QFR enzyme, which either change their protonation state and/or experience an environmental change in the course of the induced redox reaction. This finding was supported by the fact that the relevant FTIR difference signals are sensitive to an isotopic hydrogen/deuterium (1H/2H) exchange via the buffer solution, since they were shifted towards lower wavenumbers in D2O. Furthermore, it could be shown with the help of site-directed mutagenesis that the acidic residue Glu C180, which is located in the membranespanning, diheme-containing subunit C of QFR, is contributing to the redox dependent signal of protonated carboxyl groups. The observed residual signal in the FTIR double-difference spectrum of QFR wild-type and enzyme variant E180Q (Glu C180 has been replaced with a Gln residue) could be interpreted as a protonation/deprotonation event that is superimposed by an environmental effect on the specific C=O vibration. This result strongly supports the proposed “E-pathway” of coupled transmembrane electron and proton transfer in the QFR enzyme, which states that residue Glu C180 is an essential constituent of a transient redox-controlled transmembrane proton transfer pathway. 4.) As a second possible constituent of the suggested “E-pathway”, the ring C propionate of the distal heme was found to be unusually fully protonated in all simulated redox states, indicating a possible role as a transient proton donor/acceptor in the “E-pathway”. Similarly to Glu C180, experimental evidence from FTIR difference spectroscopy on a modified QFR with 13C-labeled heme propionates was obtained, which indicates an involvement of at least one of the two propionates of heme bD in proton transfer. The observed signals can tentatively be interpreted as a redox-coupled (de)protonation of the ring C propionate of bD, which is possibly xiii superimposed by a conformational or environmental change of the specific propionate. 5.) Also the observation of a strong redox Bohr effect for both heme b groups in QFR is in line with the proposed “E-pathway” hypothesis, as this effect yields a possible and well-established mechanism for the coupling of proton transfer and redox changes of the heme groups. The comparison of the observed effect in QFR WT and E180Q together with the results from FTIR spectroscopy and MCCE calculation indicate that the ring C propionate of the distal heme is dominating the pHdependence of the midpoint potential of bD, and that the corresponding group for bP is Glu C180. The origin of the redox Bohr effect for bP in the enzyme variant E180Q (which is dramatically changed with respect to the WT) could not be identified unequivocally, but the observation of this redox Bohr effect in the variant implies the presence of other protolytic groups, which interact with heme bP and which may be necessary for a functional “E-pathway”.
CD4+CD25+ regulatory T cells (Tregs) represent a specialized subpopulation of T cells, which are essential for maintaining peripheral tolerance and preventing autoimmunity. The immunomodulatory effects of Tregs depend on their activation status. Here we show that, in contrast to conventional anti-CD4 monoclonal antibodies (mAbs), the humanized CD4-specific monoclonal antibody tregalizumab (BT-061) is able to selectively activate the suppressive properties of Tregs in vitro. BT-061 activates Tregs by binding to CD4 and activation of signaling downstream pathways. The specific functionality of BT-061 may be explained by the recognition of a unique, conformational epitope on domain 2 of the CD4 molecule that is not recognized by other anti-CD4 mAbs. We found that, due to this special epitope binding, BT-061 induces a unique phosphorylation of T-cell receptor complex-associated signaling molecules. This is sufficient to activate the function of Tregs without activating effector T cells. Furthermore, BT-061 does not induce the release of pro-inflammatory cytokines. These results demonstrate that BT-061 stimulation via the CD4 receptor is able to induce T-cell receptor-independent activation of Tregs. Selective activation of Tregs via CD4 is a promising approach for the treatment of autoimmune diseases where insufficient Treg activity has been described. Clinical investigation of this new approach is currently ongoing.
The E-pathway of transmembrane proton transfer has been demonstrated previously to be essential for catalysis by the diheme-containing quinol:fumarate reductase (QFR) of Wolinella succinogenes. Two constituents of this pathway, Glu-C180 and heme b(D) ring C (b(D)-C-) propionate, have been validated experimentally. Here, we identify further constituents of the E-pathway by analysis of molecular dynamics simulations. The redox state of heme groups has a crucial effect on the connectivity patterns of mobile internal water molecules that can transiently support proton transfer from the b(D)-C-propionate to Glu-C180. The short H-bonding paths formed in the reduced states can lead to high proton conduction rates and thus provide a plausible explanation for the required opening of the E-pathway in reduced QFR. We found evidence that the b(D)-C-propionate group is the previously postulated branching point connecting proton transfer to the E-pathway from the quinol-oxidation site via interactions with the heme b(D) ligand His-C44. An essential functional role of His-C44 is supported experimentally by site-directed mutagenesis resulting in its replacement with Glu. Although the H44E variant enzyme retains both heme groups, it is unable to catalyze quinol oxidation. All results obtained are relevant to the QFR enzymes from the human pathogens Campylobacter jejuni and Helicobacter pylori.
The nuclear magnetic resonance of 133Cs (I=7/2) has been studied at room temperature in the isostructural compounds Cs2CuCl4, Cs2CuBr4, Cs2CoCl4 and Cs2ZnCl4. The nuclear quadrupole coupling tensors and the magnetic shift tensors have been determined at the two inequivalent sites of the unit cell for all complexes. A satisfactory description of the quadrupole coupling (νq ≲ 20 kc) with a point charge model is only possible by reducing the charge on the central ion of the MX4 tetrahedron to +1-1. Large isotropic shifts (up to 0.5%) with smaller anisotropic contributions have been found in the paramagnetic compounds. The diamagnetic Cs2ZnCl4 shows shift up to 0.03% relative to CsCl.
Die Winkelabhängigkeit des ZEEMAN-Effektes der Kernquadrupolresonanzen (35Cl) eines Einkristalls von ortho-Dichlorbenzol wurde bei — 35°C vermessen. Das Kristallsystem ist monoklin. Die z-Achsen der Feldgradiententensoren im Molekül bilden einen Winkel von (64,7 ±0,5)°. Der Asymmetrieparameter des Feldgradienten hat einen Wert von 0,100 ± 0,01. Die Winkelmeßeinrichtung wird beschrieben.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) has been identified as high-risk subgroup of acute T-lymphoblastic leukemia (T-ALL) with a high rate of FLT3-mutations in adults. To unravel the underlying pathomechanisms and the clinical course we assessed molecular alterations and clinical characteristics in a large cohort of ETP-ALL (n = 68) in comparison to non-ETP T-ALL adult patients. Interestingly, we found a high rate of FLT3-mutations in ETP-ALL samples (n = 24, 35%). Furthermore, FLT3 mutated ETP-ALL was characterized by a specific immunophenotype (CD2+/CD5-/CD13+/CD33-), a distinct gene expression pattern (aberrant expression of IGFBP7, WT1, GATA3) and mutational status (absence of NOTCH1 mutations and a low frequency, 21%, of clonal TCR rearrangements). The observed low GATA3 expression and high WT1 expression in combination with lack of NOTCH1 mutations and a low rate of TCR rearrangements point to a leukemic transformation at the pluripotent prothymocyte stage in FLT3 mutated ETP-ALL. The clinical outcome in ETP-ALL patients was poor, but encouraging in those patients with allogeneic stem cell transplantation (3-year OS: 74%). To further explore the efficacy of targeted therapies, we demonstrate that T-ALL cell lines transfected with FLT3 expression constructs were particularly sensitive to tyrosine kinase inhibitors. In conclusion, FLT3 mutated ETP-ALL defines a molecular distinct stem cell like leukemic subtype. These data warrant clinical studies with the implementation of FLT3 inhibitors in addition to early allogeneic stem cell transplantation for this high risk subgroup.
Background: Balloon pulmonary angioplasty is an evolving, interventional treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary hypertension at rest as well as exercise capacity is considered to be relevant outcome parameters. The aim of the present study was to determine whether measurement of pulmonary hemodynamics during exercise before and six months after balloon pulmonary angioplasty have an added value.
Methods: From March 2014 to July 2018, 172 consecutive patients underwent balloon pulmonary angioplasty. Of these, 64 consecutive patients with inoperable CTEPH underwent a comprehensive diagnostic workup that included right heart catheterization at rest and during exercise before balloon pulmonary angioplasty treatments and six months after the last intervention.
Results: Improvements in pulmonary hemodynamics at rest and during exercise, in quality of life, and in exercise capacity were observed six months after balloon pulmonary angioplasty: WHO functional class improved in 78% of patients. The mean pulmonary arterial pressure (mPAP) at rest was reduced from 41 ± 9 to 31 ± 9 mmHg (p < 0.0001). The mPAP/cardiac output slope decreased after balloon pulmonary angioplasty (11.2 ± 25.6 WU to 7.7 ± 4.1 WU; p < 0.0001), and correlated with N-terminal fragment of pro-brain natriuretic peptide (p = 0.035) and 6-minute walking distance (p = 0.01).
Conclusions: Exercise right heart catheterization provides valuable information on the changes of pulmonary hemodynamics after balloon pulmonary angioplasty in inoperable CTEPH patients that are not obtainable by measuring resting hemodynamics.